Delivery Order SPE2DB24D6038-SPE2DB25FEMHC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,075.80 for Latuda 120 mg tablets (30-count supply) on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply agreement running...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Latuda 120 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $9,820.56. The order is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's proven...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Latuda 60 mg tablets in quantities of 30 units, with a contract ceiling value of $3,132.62. This firm fixed-price delivery order is non-competitive and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract is scheduled for completion by April 22, 2025, and will be fulfilled from the contractor's facility in...
- The Defense Logistics Agency awarded a $7,123.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Latuda 40 mg tablets, with completion scheduled for June 26, 2025. This delivery order was awarded competitively without set-aside restrictions and represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply framework. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D6038Indefinite Delivery Contract
- SPE2DB24D6038-SPE2DB25FEMHCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Latuda 20 mg tablets (30-count) valued at $4,191.82 under a firm fixed-price contract. The award was made on May 14, 2025, with an ultimate completion date of May 15, 2025, and the product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. Latuda, an atypical antipsychotic medication, falls within the neurological treatment category that AmerisourceBergen routinely provides through this vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/14/25 |